The UMC Utrecht Brain Centre, in collaboration with various organizations in the Netherlands, will receive around $1.5 million (€1.4 million) from the Dutch government. Bedrocan announced the study on March 20. Previous research showed that CBD reduced seizures in affected children Certain syndromes associated with epilepsy.
C company based in the United KingdomGrapes Health News reports It via the government or ZonMW Good Use of Medicines ProgramThe researchers will use the funds and launch a four-year research project to delve deeper into the effects of high CBD oil on children with severe epilepsy.
The researchers will administer a high CBD whole plant oil, Bedrolite from the Dutch Transvaal Pharmacy, which is made using the hemp it produces. Badroukan. Fifty participants will join the experiment, which is scheduled to launch in the summer. The first patients are expected to start by the end of the year.
Researchers will study whether the oil is effective in reducing the frequency of celiac disease seizures. They will also monitor other “quality of life indicators” such as seizure length, Sleepsand vigilance. Patients should not use it before CBD oil For epilepsy and/or seizures and there must be at least eight or more seizures every four weeks.
Our research focuses on the individual. Instead of looking at a group, we look at whether a drug is effective for each patient, said the lead researcher, Floor Jansen, a pediatric neurologist. “We want to investigate whether the number of attacks has decreased, but we’re also paying attention to other important patient outcomes. Consider less use of emergency medications against prolonged seizures, a change in alertness or a better night’s sleep.”
Rare and intractable forms of epilepsy have not been studied well enough. Researchers will look at individual cases rather than the group as a whole to determine if the drug is effective for each patient.
Intractable epilepsy It is a charity that raises funds to help families pay for cannabis prescriptions. Jo Griffiths, chair of intractable epilepsy, said she would like to see the UK match €1.4 million for randomized control trials (RCTs) on Bedrocan products.
“Intractable epilepsy supports families who can afford to pay for private medical cannabis treatment, once they have been prescribed it for at least six months,” Griffiths said. But some families can’t even afford private counseling. To help every child and young person with intractable epilepsy gain access to whole-grain medical cannabis, the government and health providers say gold standards randomized controlled trials are needed. Therefore, we are calling on the UK government to match €1.4m to the Dutch government for the trials, and to run an NHS trial using the same oils.”
“The NHS has prescribed the same oils to two children in the UK over the past four years, while others pay privately and some families look to the unregulated black market,” she said.
In addition to randomized controlled trials, intractable epilepsy is seeking an observational study to examine the effects of whole cannabis oils on people who have already had success with the compound.
She added: “Alongside the randomized controlled trials in the UK, we would like to see the observational trial recommended by the Health Select Committee in 2019, for those already taking whole-extract oils.”
“It would be wise for the government and the NHS to get involved in these trials to build the evidence base that has been demonstrated by more than 50 children over the last four years.”
The study will begin this summer, and the first patients are expected to be treated by the end of 2023.
